nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—RPS6KA3—Acetylsalicylic acid—Kawasaki disease	0.413	0.981	CbGbCtD
Sunitinib—BLK—Kawasaki disease	0.403	1	CbGaD
Sunitinib—ABCB1—Acetylsalicylic acid—Kawasaki disease	0.00811	0.0193	CbGbCtD
Sunitinib—MYLK—umbilical vein—Kawasaki disease	0.00167	0.0173	CbGeAlD
Sunitinib—KCNH2—endocardium—Kawasaki disease	0.00161	0.0166	CbGeAlD
Sunitinib—ERN1—endothelium—Kawasaki disease	0.00126	0.0129	CbGeAlD
Sunitinib—MYLK2—heart—Kawasaki disease	0.00104	0.0107	CbGeAlD
Sunitinib—MYLK3—cardiac ventricle—Kawasaki disease	0.000991	0.0102	CbGeAlD
Sunitinib—MYLK—artery—Kawasaki disease	0.00094	0.00968	CbGeAlD
Sunitinib—FLT1—umbilical vein—Kawasaki disease	0.000933	0.00961	CbGeAlD
Sunitinib—DYRK2—skin of body—Kawasaki disease	0.000868	0.00894	CbGeAlD
Sunitinib—PRKAA2—cardiac ventricle—Kawasaki disease	0.000834	0.00859	CbGeAlD
Sunitinib—MYLK—endothelium—Kawasaki disease	0.000794	0.00818	CbGeAlD
Sunitinib—KDR—umbilical vein—Kawasaki disease	0.000789	0.00813	CbGeAlD
Sunitinib—PRKAA2—myocardium—Kawasaki disease	0.000785	0.00808	CbGeAlD
Sunitinib—STK17A—cardiac ventricle—Kawasaki disease	0.00074	0.00762	CbGeAlD
Sunitinib—GRK4—heart—Kawasaki disease	0.000723	0.00745	CbGeAlD
Sunitinib—LATS2—cardiac ventricle—Kawasaki disease	0.000719	0.00741	CbGeAlD
Sunitinib—MYLK—gall bladder—Kawasaki disease	0.000689	0.0071	CbGeAlD
Sunitinib—LATS2—myocardium—Kawasaki disease	0.000676	0.00697	CbGeAlD
Sunitinib—TLK2—heart—Kawasaki disease	0.000672	0.00692	CbGeAlD
Sunitinib—RPS6KA5—myocardium—Kawasaki disease	0.000667	0.00687	CbGeAlD
Sunitinib—MYLK3—heart—Kawasaki disease	0.000651	0.0067	CbGeAlD
Sunitinib—BRD4—cardiac ventricle—Kawasaki disease	0.000639	0.00658	CbGeAlD
Sunitinib—TNIK—cardiac ventricle—Kawasaki disease	0.00062	0.00639	CbGeAlD
Sunitinib—ICK—cardiac ventricle—Kawasaki disease	0.000609	0.00627	CbGeAlD
Sunitinib—BRD4—myocardium—Kawasaki disease	0.000601	0.00619	CbGeAlD
Sunitinib—RIOK1—myocardium—Kawasaki disease	0.000595	0.00613	CbGeAlD
Sunitinib—NUAK1—cardiac ventricle—Kawasaki disease	0.000588	0.00606	CbGeAlD
Sunitinib—TNIK—myocardium—Kawasaki disease	0.000583	0.00601	CbGeAlD
Sunitinib—OXSR1—cardiac ventricle—Kawasaki disease	0.000583	0.00601	CbGeAlD
Sunitinib—SNRK—cardiac ventricle—Kawasaki disease	0.000583	0.00601	CbGeAlD
Sunitinib—INSR—cardiac ventricle—Kawasaki disease	0.000583	0.00601	CbGeAlD
Sunitinib—SGK3—myocardium—Kawasaki disease	0.000578	0.00595	CbGeAlD
Sunitinib—STK38—cardiac ventricle—Kawasaki disease	0.000574	0.00591	CbGeAlD
Sunitinib—RPS6KA2—cardiac ventricle—Kawasaki disease	0.000574	0.00591	CbGeAlD
Sunitinib—FLT4—endothelium—Kawasaki disease	0.000569	0.00586	CbGeAlD
Sunitinib—PKN1—cardiac ventricle—Kawasaki disease	0.000565	0.00582	CbGeAlD
Sunitinib—CSNK1G2—cardiac ventricle—Kawasaki disease	0.000565	0.00582	CbGeAlD
Sunitinib—PRPF4—cardiac ventricle—Kawasaki disease	0.000557	0.00573	CbGeAlD
Sunitinib—NUAK1—myocardium—Kawasaki disease	0.000553	0.0057	CbGeAlD
Sunitinib—PRPF4B—cardiac ventricle—Kawasaki disease	0.000549	0.00565	CbGeAlD
Sunitinib—OXSR1—myocardium—Kawasaki disease	0.000548	0.00565	CbGeAlD
Sunitinib—SNRK—myocardium—Kawasaki disease	0.000548	0.00565	CbGeAlD
Sunitinib—INSR—myocardium—Kawasaki disease	0.000548	0.00565	CbGeAlD
Sunitinib—PIP4K2B—heart—Kawasaki disease	0.000548	0.00564	CbGeAlD
Sunitinib—PRKAA2—heart—Kawasaki disease	0.000548	0.00564	CbGeAlD
Sunitinib—ERN1—heart—Kawasaki disease	0.000548	0.00564	CbGeAlD
Sunitinib—STK39—cardiac ventricle—Kawasaki disease	0.000541	0.00558	CbGeAlD
Sunitinib—STK38—myocardium—Kawasaki disease	0.00054	0.00556	CbGeAlD
Sunitinib—RPS6KA2—myocardium—Kawasaki disease	0.00054	0.00556	CbGeAlD
Sunitinib—CSNK2A1—cardiac ventricle—Kawasaki disease	0.000534	0.0055	CbGeAlD
Sunitinib—STK17B—heart—Kawasaki disease	0.000527	0.00543	CbGeAlD
Sunitinib—MYLK—cardiac ventricle—Kawasaki disease	0.000527	0.00543	CbGeAlD
Sunitinib—PRPF4—myocardium—Kawasaki disease	0.000524	0.00539	CbGeAlD
Sunitinib—FLT1—artery—Kawasaki disease	0.000524	0.00539	CbGeAlD
Sunitinib—PRPF4B—myocardium—Kawasaki disease	0.000516	0.00532	CbGeAlD
Sunitinib—STK39—myocardium—Kawasaki disease	0.000509	0.00524	CbGeAlD
Sunitinib—CSNK2A1—myocardium—Kawasaki disease	0.000502	0.00518	CbGeAlD
Sunitinib—DAPK2—cardiac ventricle—Kawasaki disease	0.0005	0.00515	CbGeAlD
Sunitinib—MYLK—myocardium—Kawasaki disease	0.000496	0.00511	CbGeAlD
Sunitinib—HIPK3—cardiac ventricle—Kawasaki disease	0.000489	0.00504	CbGeAlD
Sunitinib—STK17A—heart—Kawasaki disease	0.000486	0.005	CbGeAlD
Sunitinib—RIOK2—cardiac ventricle—Kawasaki disease	0.000484	0.00499	CbGeAlD
Sunitinib—CDK14—heart—Kawasaki disease	0.000479	0.00493	CbGeAlD
Sunitinib—CDK16—heart—Kawasaki disease	0.000472	0.00486	CbGeAlD
Sunitinib—LATS2—heart—Kawasaki disease	0.000472	0.00486	CbGeAlD
Sunitinib—DAPK2—myocardium—Kawasaki disease	0.00047	0.00484	CbGeAlD
Sunitinib—DAPK3—cardiac ventricle—Kawasaki disease	0.00047	0.00484	CbGeAlD
Sunitinib—STK33—heart—Kawasaki disease	0.000466	0.0048	CbGeAlD
Sunitinib—RPS6KA5—heart—Kawasaki disease	0.000466	0.0048	CbGeAlD
Sunitinib—CDK16—skin of body—Kawasaki disease	0.000462	0.00476	CbGeAlD
Sunitinib—HIPK3—myocardium—Kawasaki disease	0.00046	0.00474	CbGeAlD
Sunitinib—RIOK2—myocardium—Kawasaki disease	0.000455	0.00469	CbGeAlD
Sunitinib—CLK4—heart—Kawasaki disease	0.000448	0.00462	CbGeAlD
Sunitinib—KDR—artery—Kawasaki disease	0.000443	0.00456	CbGeAlD
Sunitinib—FLT1—endothelium—Kawasaki disease	0.000442	0.00456	CbGeAlD
Sunitinib—DAPK3—myocardium—Kawasaki disease	0.000442	0.00455	CbGeAlD
Sunitinib—PHKG1—heart—Kawasaki disease	0.000433	0.00446	CbGeAlD
Sunitinib—DAPK1—heart—Kawasaki disease	0.000433	0.00446	CbGeAlD
Sunitinib—MAP4K4—cardiac ventricle—Kawasaki disease	0.000422	0.00435	CbGeAlD
Sunitinib—STK11—heart—Kawasaki disease	0.000419	0.00432	CbGeAlD
Sunitinib—BRD4—heart—Kawasaki disease	0.000419	0.00432	CbGeAlD
Sunitinib—RPS6KA1—heart—Kawasaki disease	0.000415	0.00428	CbGeAlD
Sunitinib—RIOK1—heart—Kawasaki disease	0.000415	0.00428	CbGeAlD
Sunitinib—DYRK1A—myocardium—Kawasaki disease	0.000414	0.00426	CbGeAlD
Sunitinib—RPS6KA3—cardiac ventricle—Kawasaki disease	0.00041	0.00423	CbGeAlD
Sunitinib—TNIK—heart—Kawasaki disease	0.000407	0.00419	CbGeAlD
Sunitinib—MARK2—heart—Kawasaki disease	0.000407	0.00419	CbGeAlD
Sunitinib—MAP2K1—neck—Kawasaki disease	0.000405	0.00417	CbGeAlD
Sunitinib—SGK3—heart—Kawasaki disease	0.000403	0.00415	CbGeAlD
Sunitinib—CSNK1A1—cardiac ventricle—Kawasaki disease	0.000402	0.00414	CbGeAlD
Sunitinib—ICK—heart—Kawasaki disease	0.0004	0.00412	CbGeAlD
Sunitinib—CLK1—cardiac ventricle—Kawasaki disease	0.0004	0.00412	CbGeAlD
Sunitinib—CSNK1A1—neck—Kawasaki disease	0.000399	0.00412	CbGeAlD
Sunitinib—CLK1—neck—Kawasaki disease	0.000397	0.00409	CbGeAlD
Sunitinib—MAP4K4—myocardium—Kawasaki disease	0.000397	0.00409	CbGeAlD
Sunitinib—BMP2K—neck—Kawasaki disease	0.00039	0.00401	CbGeAlD
Sunitinib—NUAK1—heart—Kawasaki disease	0.000386	0.00398	CbGeAlD
Sunitinib—RPS6KA3—myocardium—Kawasaki disease	0.000386	0.00397	CbGeAlD
Sunitinib—OXSR1—heart—Kawasaki disease	0.000383	0.00394	CbGeAlD
Sunitinib—SNRK—heart—Kawasaki disease	0.000383	0.00394	CbGeAlD
Sunitinib—INSR—heart—Kawasaki disease	0.000383	0.00394	CbGeAlD
Sunitinib—CSNK1A1—myocardium—Kawasaki disease	0.000378	0.0039	CbGeAlD
Sunitinib—STK38—heart—Kawasaki disease	0.000377	0.00388	CbGeAlD
Sunitinib—RPS6KA2—heart—Kawasaki disease	0.000377	0.00388	CbGeAlD
Sunitinib—CLK1—myocardium—Kawasaki disease	0.000376	0.00387	CbGeAlD
Sunitinib—INSR—skin of body—Kawasaki disease	0.000375	0.00386	CbGeAlD
Sunitinib—KDR—endothelium—Kawasaki disease	0.000374	0.00385	CbGeAlD
Sunitinib—AURKC—heart—Kawasaki disease	0.000374	0.00385	CbGeAlD
Sunitinib—CSNK1E—cardiac ventricle—Kawasaki disease	0.000373	0.00384	CbGeAlD
Sunitinib—PKN1—heart—Kawasaki disease	0.000371	0.00382	CbGeAlD
Sunitinib—CSNK1G2—heart—Kawasaki disease	0.000371	0.00382	CbGeAlD
Sunitinib—PRPF4—heart—Kawasaki disease	0.000365	0.00377	CbGeAlD
Sunitinib—CSNK1G2—skin of body—Kawasaki disease	0.000363	0.00374	CbGeAlD
Sunitinib—PRPF4B—heart—Kawasaki disease	0.00036	0.00371	CbGeAlD
Sunitinib—PDGFRA—gall bladder—Kawasaki disease	0.00036	0.0037	CbGeAlD
Sunitinib—ULK3—cardiac ventricle—Kawasaki disease	0.000359	0.0037	CbGeAlD
Sunitinib—MAP2K2—cardiac ventricle—Kawasaki disease	0.000359	0.0037	CbGeAlD
Sunitinib—STK39—heart—Kawasaki disease	0.000355	0.00366	CbGeAlD
Sunitinib—MAP3K7—cardiac ventricle—Kawasaki disease	0.000353	0.00363	CbGeAlD
Sunitinib—CSNK2A1—heart—Kawasaki disease	0.000351	0.00361	CbGeAlD
Sunitinib—FGFR1—myocardium—Kawasaki disease	0.00035	0.00361	CbGeAlD
Sunitinib—TBK1—cardiac ventricle—Kawasaki disease	0.000349	0.00359	CbGeAlD
Sunitinib—TBK1—neck—Kawasaki disease	0.000346	0.00357	CbGeAlD
Sunitinib—TYK2—cardiac ventricle—Kawasaki disease	0.000346	0.00357	CbGeAlD
Sunitinib—MYLK—heart—Kawasaki disease	0.000346	0.00357	CbGeAlD
Sunitinib—IRAK1—cardiac ventricle—Kawasaki disease	0.000342	0.00352	CbGeAlD
Sunitinib—STK4—heart—Kawasaki disease	0.00034	0.0035	CbGeAlD
Sunitinib—MYLK—skin of body—Kawasaki disease	0.000339	0.00349	CbGeAlD
Sunitinib—MAP2K2—myocardium—Kawasaki disease	0.000337	0.00348	CbGeAlD
Sunitinib—ULK3—myocardium—Kawasaki disease	0.000337	0.00348	CbGeAlD
Sunitinib—RPS6KB1—cardiac ventricle—Kawasaki disease	0.000335	0.00346	CbGeAlD
Sunitinib—PHKG2—heart—Kawasaki disease	0.000334	0.00344	CbGeAlD
Sunitinib—RPS6KB1—neck—Kawasaki disease	0.000333	0.00343	CbGeAlD
Sunitinib—AXL—cardiac ventricle—Kawasaki disease	0.000332	0.00342	CbGeAlD
Sunitinib—STK24—heart—Kawasaki disease	0.000332	0.00342	CbGeAlD
Sunitinib—MAP3K7—myocardium—Kawasaki disease	0.000332	0.00342	CbGeAlD
Sunitinib—KIT—endothelium—Kawasaki disease	0.000331	0.00341	CbGeAlD
Sunitinib—RET—neck—Kawasaki disease	0.000331	0.00341	CbGeAlD
Sunitinib—DAPK2—heart—Kawasaki disease	0.000328	0.00338	CbGeAlD
Sunitinib—TBK1—myocardium—Kawasaki disease	0.000328	0.00338	CbGeAlD
Sunitinib—TYK2—myocardium—Kawasaki disease	0.000326	0.00336	CbGeAlD
Sunitinib—STK24—skin of body—Kawasaki disease	0.000325	0.00335	CbGeAlD
Sunitinib—STK16—heart—Kawasaki disease	0.000323	0.00333	CbGeAlD
Sunitinib—IRAK1—myocardium—Kawasaki disease	0.000322	0.00331	CbGeAlD
Sunitinib—HIPK3—heart—Kawasaki disease	0.000321	0.00331	CbGeAlD
Sunitinib—HIPK2—heart—Kawasaki disease	0.000321	0.00331	CbGeAlD
Sunitinib—SLK—cardiac ventricle—Kawasaki disease	0.00032	0.00329	CbGeAlD
Sunitinib—RIOK2—heart—Kawasaki disease	0.000318	0.00327	CbGeAlD
Sunitinib—TNK1—heart—Kawasaki disease	0.000318	0.00327	CbGeAlD
Sunitinib—RPS6KB1—myocardium—Kawasaki disease	0.000316	0.00325	CbGeAlD
Sunitinib—JAK2—cardiac ventricle—Kawasaki disease	0.000315	0.00325	CbGeAlD
Sunitinib—FGFR2—neck—Kawasaki disease	0.000315	0.00324	CbGeAlD
Sunitinib—MAP4K1—heart—Kawasaki disease	0.000315	0.00324	CbGeAlD
Sunitinib—TYRO3—skin of body—Kawasaki disease	0.000314	0.00324	CbGeAlD
Sunitinib—AXL—myocardium—Kawasaki disease	0.000312	0.00322	CbGeAlD
Sunitinib—FYN—cardiac ventricle—Kawasaki disease	0.000311	0.0032	CbGeAlD
Sunitinib—DAPK3—heart—Kawasaki disease	0.000308	0.00318	CbGeAlD
Sunitinib—CLK2—heart—Kawasaki disease	0.000306	0.00315	CbGeAlD
Sunitinib—MAP4K2—heart—Kawasaki disease	0.000304	0.00313	CbGeAlD
Sunitinib—MAP3K3—cardiac ventricle—Kawasaki disease	0.000304	0.00313	CbGeAlD
Sunitinib—SLK—myocardium—Kawasaki disease	0.000301	0.0031	CbGeAlD
Sunitinib—STK3—heart—Kawasaki disease	0.0003	0.00309	CbGeAlD
Sunitinib—JAK2—myocardium—Kawasaki disease	0.000296	0.00305	CbGeAlD
Sunitinib—ROCK1—heart—Kawasaki disease	0.000296	0.00305	CbGeAlD
Sunitinib—FLT1—cardiac ventricle—Kawasaki disease	0.000294	0.00303	CbGeAlD
Sunitinib—FYN—myocardium—Kawasaki disease	0.000292	0.00301	CbGeAlD
Sunitinib—FLT1—neck—Kawasaki disease	0.000292	0.00301	CbGeAlD
Sunitinib—DYRK1A—heart—Kawasaki disease	0.000289	0.00298	CbGeAlD
Sunitinib—KIT—gall bladder—Kawasaki disease	0.000287	0.00296	CbGeAlD
Sunitinib—MAP3K3—myocardium—Kawasaki disease	0.000286	0.00294	CbGeAlD
Sunitinib—MERTK—heart—Kawasaki disease	0.000282	0.00291	CbGeAlD
Sunitinib—PDGFRB—gall bladder—Kawasaki disease	0.000281	0.00289	CbGeAlD
Sunitinib—YES1—cardiac ventricle—Kawasaki disease	0.000281	0.00289	CbGeAlD
Sunitinib—MAP4K4—heart—Kawasaki disease	0.000277	0.00285	CbGeAlD
Sunitinib—TAOK3—cardiac ventricle—Kawasaki disease	0.000277	0.00285	CbGeAlD
Sunitinib—FLT1—myocardium—Kawasaki disease	0.000276	0.00285	CbGeAlD
Sunitinib—FLT3—heart—Kawasaki disease	0.000273	0.00281	CbGeAlD
Sunitinib—MAP3K12—heart—Kawasaki disease	0.000273	0.00281	CbGeAlD
Sunitinib—RPS6KA3—heart—Kawasaki disease	0.000269	0.00277	CbGeAlD
Sunitinib—MAP2K1—heart—Kawasaki disease	0.000267	0.00276	CbGeAlD
Sunitinib—CSNK1A1—heart—Kawasaki disease	0.000264	0.00272	CbGeAlD
Sunitinib—YES1—myocardium—Kawasaki disease	0.000264	0.00272	CbGeAlD
Sunitinib—CLK1—heart—Kawasaki disease	0.000262	0.0027	CbGeAlD
Sunitinib—MAP2K1—skin of body—Kawasaki disease	0.000262	0.0027	CbGeAlD
Sunitinib—TAOK3—myocardium—Kawasaki disease	0.00026	0.00268	CbGeAlD
Sunitinib—CSNK1A1—skin of body—Kawasaki disease	0.000259	0.00266	CbGeAlD
Sunitinib—CAMK2G—heart—Kawasaki disease	0.000257	0.00265	CbGeAlD
Sunitinib—BMP2K—heart—Kawasaki disease	0.000257	0.00265	CbGeAlD
Sunitinib—LRRK2—heart—Kawasaki disease	0.000255	0.00263	CbGeAlD
Sunitinib—PRKAA1—heart—Kawasaki disease	0.000251	0.00259	CbGeAlD
Sunitinib—PTK2B—heart—Kawasaki disease	0.000249	0.00256	CbGeAlD
Sunitinib—KDR—cardiac ventricle—Kawasaki disease	0.000248	0.00256	CbGeAlD
Sunitinib—FLT4—heart—Kawasaki disease	0.000248	0.00255	CbGeAlD
Sunitinib—KDR—neck—Kawasaki disease	0.000247	0.00254	CbGeAlD
Sunitinib—CSNK1E—heart—Kawasaki disease	0.000245	0.00252	CbGeAlD
Sunitinib—FGFR1—heart—Kawasaki disease	0.000245	0.00252	CbGeAlD
Sunitinib—IRAK4—heart—Kawasaki disease	0.000241	0.00248	CbGeAlD
Sunitinib—CSNK1E—skin of body—Kawasaki disease	0.00024	0.00247	CbGeAlD
Sunitinib—ULK3—heart—Kawasaki disease	0.000235	0.00243	CbGeAlD
Sunitinib—MAP2K2—heart—Kawasaki disease	0.000235	0.00243	CbGeAlD
Sunitinib—MAP3K2—heart—Kawasaki disease	0.000234	0.00241	CbGeAlD
Sunitinib—KDR—myocardium—Kawasaki disease	0.000234	0.00241	CbGeAlD
Sunitinib—MAP2K5—myocardium—Kawasaki disease	0.000234	0.00241	CbGeAlD
Sunitinib—MAP3K7—heart—Kawasaki disease	0.000232	0.00239	CbGeAlD
Sunitinib—MAP2K2—skin of body—Kawasaki disease	0.000231	0.00238	CbGeAlD
Sunitinib—TBK1—heart—Kawasaki disease	0.000229	0.00236	CbGeAlD
Sunitinib—TYK2—heart—Kawasaki disease	0.000227	0.00234	CbGeAlD
Sunitinib—IRAK1—heart—Kawasaki disease	0.000224	0.00231	CbGeAlD
Sunitinib—TYK2—skin of body—Kawasaki disease	0.000223	0.00229	CbGeAlD
Sunitinib—RPS6KB1—heart—Kawasaki disease	0.00022	0.00227	CbGeAlD
Sunitinib—RET—heart—Kawasaki disease	0.000219	0.00226	CbGeAlD
Sunitinib—FGR—heart—Kawasaki disease	0.000219	0.00226	CbGeAlD
Sunitinib—KIT—neck—Kawasaki disease	0.000219	0.00225	CbGeAlD
Sunitinib—AXL—heart—Kawasaki disease	0.000218	0.00225	CbGeAlD
Sunitinib—PDGFRB—cardiac ventricle—Kawasaki disease	0.000215	0.00221	CbGeAlD
Sunitinib—AXL—skin of body—Kawasaki disease	0.000214	0.0022	CbGeAlD
Sunitinib—PDGFRB—neck—Kawasaki disease	0.000213	0.0022	CbGeAlD
Sunitinib—SLK—heart—Kawasaki disease	0.00021	0.00216	CbGeAlD
Sunitinib—KIT—myocardium—Kawasaki disease	0.000207	0.00213	CbGeAlD
Sunitinib—JAK2—heart—Kawasaki disease	0.000207	0.00213	CbGeAlD
Sunitinib—FYN—heart—Kawasaki disease	0.000204	0.0021	CbGeAlD
Sunitinib—FGFR2—skin of body—Kawasaki disease	0.000204	0.0021	CbGeAlD
Sunitinib—JAK2—skin of body—Kawasaki disease	0.000203	0.00209	CbGeAlD
Sunitinib—PDGFRB—myocardium—Kawasaki disease	0.000202	0.00208	CbGeAlD
Sunitinib—FYN—skin of body—Kawasaki disease	0.0002	0.00206	CbGeAlD
Sunitinib—MAP3K3—heart—Kawasaki disease	0.000199	0.00205	CbGeAlD
Sunitinib—MAP4K5—heart—Kawasaki disease	0.000199	0.00205	CbGeAlD
Sunitinib—MAP3K3—skin of body—Kawasaki disease	0.000195	0.00201	CbGeAlD
Sunitinib—FLT1—heart—Kawasaki disease	0.000193	0.00199	CbGeAlD
Sunitinib—EPHB6—heart—Kawasaki disease	0.000191	0.00196	CbGeAlD
Sunitinib—EPHB6—skin of body—Kawasaki disease	0.000187	0.00192	CbGeAlD
Sunitinib—YES1—heart—Kawasaki disease	0.000184	0.0019	CbGeAlD
Sunitinib—STK10—heart—Kawasaki disease	0.000183	0.00188	CbGeAlD
Sunitinib—TAOK3—heart—Kawasaki disease	0.000182	0.00187	CbGeAlD
Sunitinib—PDGFRA—heart—Kawasaki disease	0.000181	0.00186	CbGeAlD
Sunitinib—KDR—heart—Kawasaki disease	0.000163	0.00168	CbGeAlD
Sunitinib—MAP2K5—heart—Kawasaki disease	0.000163	0.00168	CbGeAlD
Sunitinib—CSF1R—heart—Kawasaki disease	0.000159	0.00164	CbGeAlD
Sunitinib—CSF1R—skin of body—Kawasaki disease	0.000156	0.0016	CbGeAlD
Sunitinib—KIT—heart—Kawasaki disease	0.000144	0.00149	CbGeAlD
Sunitinib—KIT—skin of body—Kawasaki disease	0.000141	0.00146	CbGeAlD
Sunitinib—PDGFRB—heart—Kawasaki disease	0.000141	0.00145	CbGeAlD
Sunitinib—PDGFRB—skin of body—Kawasaki disease	0.000138	0.00142	CbGeAlD
Sunitinib—KCNH2—cardiac ventricle—Kawasaki disease	0.000136	0.0014	CbGeAlD
Sunitinib—KCNH2—myocardium—Kawasaki disease	0.000128	0.00132	CbGeAlD
Sunitinib—ABCC4—heart—Kawasaki disease	0.000112	0.00116	CbGeAlD
Sunitinib—KCNH2—heart—Kawasaki disease	8.91e-05	0.000918	CbGeAlD
Sunitinib—ABCG2—heart—Kawasaki disease	7.93e-05	0.000817	CbGeAlD
Sunitinib—ABCB1—heart—Kawasaki disease	3.91e-05	0.000403	CbGeAlD
Sunitinib—FYN—Immune System—FCGR2A—Kawasaki disease	1.54e-05	0.000197	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—CD40—Kawasaki disease	1.54e-05	0.000197	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—FCGR2A—Kawasaki disease	1.54e-05	0.000196	CbGpPWpGaD
Sunitinib—ROCK1—Developmental Biology—MMP9—Kawasaki disease	1.53e-05	0.000196	CbGpPWpGaD
Sunitinib—STK4—Signaling Pathways—VEGFA—Kawasaki disease	1.53e-05	0.000196	CbGpPWpGaD
Sunitinib—RPS6KA3—Immune System—CRP—Kawasaki disease	1.52e-05	0.000194	CbGpPWpGaD
Sunitinib—KIT—Immune System—CD40—Kawasaki disease	1.51e-05	0.000193	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—CD40—Kawasaki disease	1.51e-05	0.000193	CbGpPWpGaD
Sunitinib—BLK—Adaptive Immune System—CD4—Kawasaki disease	1.51e-05	0.000193	CbGpPWpGaD
Sunitinib—FYN—Immune System—BLK—Kawasaki disease	1.5e-05	0.000191	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—CCR5—Kawasaki disease	1.49e-05	0.000191	CbGpPWpGaD
Sunitinib—JAK2—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	1.49e-05	0.00019	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—BLK—Kawasaki disease	1.49e-05	0.00019	CbGpPWpGaD
Sunitinib—FGFR1—Axon guidance—MMP9—Kawasaki disease	1.48e-05	0.00019	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—CCR5—Kawasaki disease	1.48e-05	0.000189	CbGpPWpGaD
Sunitinib—JAK2—Immune System—FCGR2A—Kawasaki disease	1.47e-05	0.000188	CbGpPWpGaD
Sunitinib—MAP2K2—Innate Immune System—CRP—Kawasaki disease	1.46e-05	0.000187	CbGpPWpGaD
Sunitinib—STK3—Signaling Pathways—MMP9—Kawasaki disease	1.45e-05	0.000185	CbGpPWpGaD
Sunitinib—RPS6KA5—Immune System—CD4—Kawasaki disease	1.45e-05	0.000185	CbGpPWpGaD
Sunitinib—TYK2—Axon guidance—VEGFA—Kawasaki disease	1.45e-05	0.000185	CbGpPWpGaD
Sunitinib—Haematemesis—Acetylsalicylic acid—Kawasaki disease	1.44e-05	0.101	CcSEcCtD
Sunitinib—KDR—Developmental Biology—MMP9—Kawasaki disease	1.44e-05	0.000184	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—CD40—Kawasaki disease	1.44e-05	0.000184	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—CD40—Kawasaki disease	1.43e-05	0.000183	CbGpPWpGaD
Sunitinib—RPS6KA2—Immune System—CD4—Kawasaki disease	1.43e-05	0.000183	CbGpPWpGaD
Sunitinib—PDGFRB—Innate Immune System—CRP—Kawasaki disease	1.43e-05	0.000183	CbGpPWpGaD
Sunitinib—JAK2—Immune System—BLK—Kawasaki disease	1.42e-05	0.000182	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—CCR5—Kawasaki disease	1.41e-05	0.00018	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—CRP—Kawasaki disease	1.39e-05	0.000178	CbGpPWpGaD
Sunitinib—FYN—Innate Immune System—CRP—Kawasaki disease	1.38e-05	0.000176	CbGpPWpGaD
Sunitinib—ROCK1—Developmental Biology—VEGFA—Kawasaki disease	1.38e-05	0.000176	CbGpPWpGaD
Sunitinib—MAP2K1—Innate Immune System—CRP—Kawasaki disease	1.37e-05	0.000175	CbGpPWpGaD
Sunitinib—MAP2K2—Axon guidance—MMP9—Kawasaki disease	1.37e-05	0.000175	CbGpPWpGaD
Sunitinib—FGR—Hemostasis—VEGFA—Kawasaki disease	1.36e-05	0.000174	CbGpPWpGaD
Sunitinib—BLK—Immune System—CRP—Kawasaki disease	1.36e-05	0.000174	CbGpPWpGaD
Sunitinib—FGR—Immune System—CRP—Kawasaki disease	1.35e-05	0.000173	CbGpPWpGaD
Sunitinib—FGFR1—Axon guidance—VEGFA—Kawasaki disease	1.33e-05	0.00017	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—CCR5—Kawasaki disease	1.33e-05	0.000169	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—CD40—Kawasaki disease	1.32e-05	0.000169	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—CCR5—Kawasaki disease	1.32e-05	0.000168	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—CRP—Kawasaki disease	1.31e-05	0.000167	CbGpPWpGaD
Sunitinib—STK3—Signaling Pathways—VEGFA—Kawasaki disease	1.3e-05	0.000166	CbGpPWpGaD
Sunitinib—Hepatotoxicity—Acetylsalicylic acid—Kawasaki disease	1.3e-05	0.0907	CcSEcCtD
Sunitinib—KDR—Developmental Biology—VEGFA—Kawasaki disease	1.29e-05	0.000165	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—CD40—Kawasaki disease	1.29e-05	0.000165	CbGpPWpGaD
Sunitinib—RPS6KA1—Immune System—CD4—Kawasaki disease	1.29e-05	0.000165	CbGpPWpGaD
Sunitinib—FYN—Axon guidance—MMP9—Kawasaki disease	1.29e-05	0.000164	CbGpPWpGaD
Sunitinib—MAP2K1—Axon guidance—MMP9—Kawasaki disease	1.28e-05	0.000163	CbGpPWpGaD
Sunitinib—YES1—Innate Immune System—CD4—Kawasaki disease	1.27e-05	0.000162	CbGpPWpGaD
Sunitinib—CSNK1A1—Disease—CD4—Kawasaki disease	1.26e-05	0.000161	CbGpPWpGaD
Sunitinib—YES1—Developmental Biology—MMP9—Kawasaki disease	1.25e-05	0.00016	CbGpPWpGaD
Sunitinib—FYN—Immune System—CD40—Kawasaki disease	1.25e-05	0.000159	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—CD40—Kawasaki disease	1.24e-05	0.000158	CbGpPWpGaD
Sunitinib—MAP2K2—Axon guidance—VEGFA—Kawasaki disease	1.23e-05	0.000157	CbGpPWpGaD
Sunitinib—JAK2—Axon guidance—MMP9—Kawasaki disease	1.22e-05	0.000156	CbGpPWpGaD
Sunitinib—YES1—Adaptive Immune System—CD4—Kawasaki disease	1.22e-05	0.000155	CbGpPWpGaD
Sunitinib—CSNK1G2—Signaling Pathways—MMP9—Kawasaki disease	1.22e-05	0.000155	CbGpPWpGaD
Sunitinib—GRK1—Signaling Pathways—MMP9—Kawasaki disease	1.22e-05	0.000155	CbGpPWpGaD
Sunitinib—IRAK1—Innate Immune System—CD4—Kawasaki disease	1.2e-05	0.000154	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—CCR5—Kawasaki disease	1.18e-05	0.000151	CbGpPWpGaD
Sunitinib—JAK2—Immune System—CD40—Kawasaki disease	1.18e-05	0.000151	CbGpPWpGaD
Sunitinib—TBK1—Immune System—CD4—Kawasaki disease	1.18e-05	0.000151	CbGpPWpGaD
Sunitinib—TYK2—Innate Immune System—CD4—Kawasaki disease	1.17e-05	0.000149	CbGpPWpGaD
Sunitinib—CAMK2G—Immune System—CD4—Kawasaki disease	1.16e-05	0.000148	CbGpPWpGaD
Sunitinib—FYN—Axon guidance—VEGFA—Kawasaki disease	1.15e-05	0.000147	CbGpPWpGaD
Sunitinib—AXL—Signaling Pathways—MMP9—Kawasaki disease	1.15e-05	0.000147	CbGpPWpGaD
Sunitinib—FGFR2—Innate Immune System—CD4—Kawasaki disease	1.15e-05	0.000147	CbGpPWpGaD
Sunitinib—TYK2—Developmental Biology—MMP9—Kawasaki disease	1.15e-05	0.000147	CbGpPWpGaD
Sunitinib—MAP2K1—Axon guidance—VEGFA—Kawasaki disease	1.15e-05	0.000147	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—CCR5—Kawasaki disease	1.14e-05	0.000145	CbGpPWpGaD
Sunitinib—MAP3K3—Immune System—CD4—Kawasaki disease	1.13e-05	0.000145	CbGpPWpGaD
Sunitinib—KIT—Innate Immune System—CD4—Kawasaki disease	1.13e-05	0.000145	CbGpPWpGaD
Sunitinib—MAP3K7—Innate Immune System—CD4—Kawasaki disease	1.13e-05	0.000145	CbGpPWpGaD
Sunitinib—YES1—Developmental Biology—VEGFA—Kawasaki disease	1.12e-05	0.000143	CbGpPWpGaD
Sunitinib—FGFR2—Adaptive Immune System—CD4—Kawasaki disease	1.11e-05	0.000141	CbGpPWpGaD
Sunitinib—YES1—Hemostasis—VEGFA—Kawasaki disease	1.1e-05	0.000141	CbGpPWpGaD
Sunitinib—JAK2—Axon guidance—VEGFA—Kawasaki disease	1.1e-05	0.00014	CbGpPWpGaD
Sunitinib—YES1—Immune System—CRP—Kawasaki disease	1.09e-05	0.00014	CbGpPWpGaD
Sunitinib—CSNK1G2—Signaling Pathways—VEGFA—Kawasaki disease	1.09e-05	0.000139	CbGpPWpGaD
Sunitinib—GRK1—Signaling Pathways—VEGFA—Kawasaki disease	1.09e-05	0.000139	CbGpPWpGaD
Sunitinib—MAP3K7—Adaptive Immune System—CD4—Kawasaki disease	1.09e-05	0.000139	CbGpPWpGaD
Sunitinib—KIT—Adaptive Immune System—CD4—Kawasaki disease	1.09e-05	0.000139	CbGpPWpGaD
Sunitinib—FGFR1—Innate Immune System—CD4—Kawasaki disease	1.07e-05	0.000137	CbGpPWpGaD
Sunitinib—PDGFRA—Innate Immune System—CD4—Kawasaki disease	1.07e-05	0.000137	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—CCR5—Kawasaki disease	1.07e-05	0.000136	CbGpPWpGaD
Sunitinib—FGFR1—Developmental Biology—MMP9—Kawasaki disease	1.06e-05	0.000135	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—CCR5—Kawasaki disease	1.06e-05	0.000135	CbGpPWpGaD
Sunitinib—IRAK4—Immune System—CD4—Kawasaki disease	1.06e-05	0.000135	CbGpPWpGaD
Sunitinib—STK11—Signaling Pathways—MMP9—Kawasaki disease	1.05e-05	0.000135	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—CRP—Kawasaki disease	1.04e-05	0.000132	CbGpPWpGaD
Sunitinib—AXL—Signaling Pathways—VEGFA—Kawasaki disease	1.04e-05	0.000132	CbGpPWpGaD
Sunitinib—TYK2—Developmental Biology—VEGFA—Kawasaki disease	1.03e-05	0.000132	CbGpPWpGaD
Sunitinib—FGFR1—Adaptive Immune System—CD4—Kawasaki disease	1.03e-05	0.000132	CbGpPWpGaD
Sunitinib—PDGFRA—Adaptive Immune System—CD4—Kawasaki disease	1.03e-05	0.000131	CbGpPWpGaD
Sunitinib—RPS6KA3—Immune System—CD4—Kawasaki disease	1.03e-05	0.000131	CbGpPWpGaD
Sunitinib—Respiratory failure—Acetylsalicylic acid—Kawasaki disease	1.02e-05	0.0713	CcSEcCtD
Sunitinib—CSNK1E—Disease—CD4—Kawasaki disease	1.02e-05	0.00013	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—MMP9—Kawasaki disease	1.02e-05	0.00013	CbGpPWpGaD
Sunitinib—TYK2—Immune System—CRP—Kawasaki disease	1.01e-05	0.000129	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—CCR5—Kawasaki disease	1e-05	0.000128	CbGpPWpGaD
Sunitinib—TYK2—Disease—CCR5—Kawasaki disease	1e-05	0.000128	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—CRP—Kawasaki disease	9.94e-06	0.000127	CbGpPWpGaD
Sunitinib—MAP2K2—Innate Immune System—CD4—Kawasaki disease	9.89e-06	0.000126	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—CCR5—Kawasaki disease	9.89e-06	0.000126	CbGpPWpGaD
Sunitinib—FGFR2—Disease—CCR5—Kawasaki disease	9.87e-06	0.000126	CbGpPWpGaD
Sunitinib—Melaena—Acetylsalicylic acid—Kawasaki disease	9.81e-06	0.0684	CcSEcCtD
Sunitinib—MAP3K7—Immune System—CRP—Kawasaki disease	9.76e-06	0.000125	CbGpPWpGaD
Sunitinib—KIT—Immune System—CRP—Kawasaki disease	9.76e-06	0.000125	CbGpPWpGaD
Sunitinib—MAP2K2—Developmental Biology—MMP9—Kawasaki disease	9.76e-06	0.000125	CbGpPWpGaD
Sunitinib—KIT—Disease—CCR5—Kawasaki disease	9.69e-06	0.000124	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—CCR5—Kawasaki disease	9.68e-06	0.000124	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ITPKC—Kawasaki disease	9.67e-06	0.000123	CbGpPWpGaD
Sunitinib—PDGFRB—Innate Immune System—CD4—Kawasaki disease	9.65e-06	0.000123	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—MMP9—Kawasaki disease	9.65e-06	0.000123	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—MMP9—Kawasaki disease	9.65e-06	0.000123	CbGpPWpGaD
Sunitinib—FGFR1—Developmental Biology—VEGFA—Kawasaki disease	9.51e-06	0.000121	CbGpPWpGaD
Sunitinib—STK11—Signaling Pathways—VEGFA—Kawasaki disease	9.47e-06	0.000121	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—CD4—Kawasaki disease	9.4e-06	0.00012	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—CCR5—Kawasaki disease	9.4e-06	0.00012	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—MMP9—Kawasaki disease	9.35e-06	0.000119	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—CCR5—Kawasaki disease	9.33e-06	0.000119	CbGpPWpGaD
Sunitinib—FYN—Innate Immune System—CD4—Kawasaki disease	9.31e-06	0.000119	CbGpPWpGaD
Sunitinib—PDGFRB—Adaptive Immune System—CD4—Kawasaki disease	9.27e-06	0.000118	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—CCR5—Kawasaki disease	9.27e-06	0.000118	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—CRP—Kawasaki disease	9.26e-06	0.000118	CbGpPWpGaD
Sunitinib—MAP2K1—Innate Immune System—CD4—Kawasaki disease	9.26e-06	0.000118	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—CRP—Kawasaki disease	9.24e-06	0.000118	CbGpPWpGaD
Sunitinib—FGFR1—Disease—CCR5—Kawasaki disease	9.2e-06	0.000118	CbGpPWpGaD
Sunitinib—BLK—Immune System—CD4—Kawasaki disease	9.18e-06	0.000117	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—CCR5—Kawasaki disease	9.18e-06	0.000117	CbGpPWpGaD
Sunitinib—FYN—Developmental Biology—MMP9—Kawasaki disease	9.18e-06	0.000117	CbGpPWpGaD
Sunitinib—FGR—Immune System—CD4—Kawasaki disease	9.15e-06	0.000117	CbGpPWpGaD
Sunitinib—MAP2K1—Developmental Biology—MMP9—Kawasaki disease	9.13e-06	0.000117	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—VEGFA—Kawasaki disease	9.12e-06	0.000116	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—CCR5—Kawasaki disease	8.98e-06	0.000115	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—CCR5—Kawasaki disease	8.98e-06	0.000115	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—CCR5—Kawasaki disease	8.98e-06	0.000115	CbGpPWpGaD
Sunitinib—FYN—Adaptive Immune System—CD4—Kawasaki disease	8.94e-06	0.000114	CbGpPWpGaD
Sunitinib—ABCC4—Hemostasis—VEGFA—Kawasaki disease	8.89e-06	0.000114	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—CD4—Kawasaki disease	8.85e-06	0.000113	CbGpPWpGaD
Sunitinib—MAP2K2—Developmental Biology—VEGFA—Kawasaki disease	8.76e-06	0.000112	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—CCR5—Kawasaki disease	8.76e-06	0.000112	CbGpPWpGaD
Sunitinib—JAK2—Developmental Biology—MMP9—Kawasaki disease	8.72e-06	0.000111	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—VEGFA—Kawasaki disease	8.66e-06	0.000111	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—VEGFA—Kawasaki disease	8.66e-06	0.000111	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—MMP9—Kawasaki disease	8.63e-06	0.00011	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—CRP—Kawasaki disease	8.53e-06	0.000109	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—CCR5—Kawasaki disease	8.47e-06	0.000108	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—VEGFA—Kawasaki disease	8.4e-06	0.000107	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—CRP—Kawasaki disease	8.32e-06	0.000106	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—CCR5—Kawasaki disease	8.27e-06	0.000106	CbGpPWpGaD
Sunitinib—FYN—Developmental Biology—VEGFA—Kawasaki disease	8.24e-06	0.000105	CbGpPWpGaD
Sunitinib—MAP2K1—Developmental Biology—VEGFA—Kawasaki disease	8.2e-06	0.000105	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—MMP9—Kawasaki disease	8.16e-06	0.000104	CbGpPWpGaD
Sunitinib—FYN—Hemostasis—VEGFA—Kawasaki disease	8.08e-06	0.000103	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—MMP9—Kawasaki disease	8.07e-06	0.000103	CbGpPWpGaD
Sunitinib—FYN—Immune System—CRP—Kawasaki disease	8.02e-06	0.000102	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—CRP—Kawasaki disease	7.98e-06	0.000102	CbGpPWpGaD
Sunitinib—FYN—Disease—CCR5—Kawasaki disease	7.97e-06	0.000102	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—CCR5—Kawasaki disease	7.93e-06	0.000101	CbGpPWpGaD
Sunitinib—JAK2—Developmental Biology—VEGFA—Kawasaki disease	7.83e-06	0.0001	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—VEGFA—Kawasaki disease	7.75e-06	9.9e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—MMP9—Kawasaki disease	7.69e-06	9.83e-05	CbGpPWpGaD
Sunitinib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Kawasaki disease	7.68e-06	9.81e-05	CbGpPWpGaD
Sunitinib—JAK2—Hemostasis—VEGFA—Kawasaki disease	7.68e-06	9.81e-05	CbGpPWpGaD
Sunitinib—Renal impairment—Acetylsalicylic acid—Kawasaki disease	7.66e-06	0.0534	CcSEcCtD
Sunitinib—JAK2—Immune System—CRP—Kawasaki disease	7.63e-06	9.74e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—CCR5—Kawasaki disease	7.6e-06	9.71e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—CCR5—Kawasaki disease	7.58e-06	9.67e-05	CbGpPWpGaD
Sunitinib—Hypoglycaemia—Acetylsalicylic acid—Kawasaki disease	7.47e-06	0.0521	CcSEcCtD
Sunitinib—YES1—Immune System—CD4—Kawasaki disease	7.38e-06	9.43e-05	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—VEGFA—Kawasaki disease	7.33e-06	9.36e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—MMP9—Kawasaki disease	7.25e-06	9.26e-05	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—VEGFA—Kawasaki disease	7.25e-06	9.26e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—CCR5—Kawasaki disease	7.21e-06	9.21e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—MMP9—Kawasaki disease	7.2e-06	9.19e-05	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—CD4—Kawasaki disease	7e-06	8.94e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—CCR5—Kawasaki disease	7e-06	8.94e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—CCR5—Kawasaki disease	6.91e-06	8.83e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—VEGFA—Kawasaki disease	6.91e-06	8.82e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—CD4—Kawasaki disease	6.8e-06	8.68e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—CCR5—Kawasaki disease	6.79e-06	8.67e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—CCR5—Kawasaki disease	6.79e-06	8.67e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—CD4—Kawasaki disease	6.71e-06	8.57e-05	CbGpPWpGaD
Sunitinib—Hypokalaemia—Acetylsalicylic acid—Kawasaki disease	6.63e-06	0.0463	CcSEcCtD
Sunitinib—KIT—Immune System—CD4—Kawasaki disease	6.59e-06	8.42e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—CD4—Kawasaki disease	6.59e-06	8.42e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—VEGFA—Kawasaki disease	6.51e-06	8.32e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—VEGFA—Kawasaki disease	6.46e-06	8.25e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—CCR5—Kawasaki disease	6.44e-06	8.23e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—CCR5—Kawasaki disease	6.43e-06	8.21e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—CD4—Kawasaki disease	6.28e-06	8.02e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—CD4—Kawasaki disease	6.26e-06	7.99e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—CD4—Kawasaki disease	6.24e-06	7.97e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—MMP9—Kawasaki disease	6.22e-06	7.94e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—CD4—Kawasaki disease	6.2e-06	7.92e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—CD4—Kawasaki disease	6.09e-06	7.78e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—CCR5—Kawasaki disease	5.93e-06	7.58e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—MMP9—Kawasaki disease	5.83e-06	7.45e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CCR5—Kawasaki disease	5.79e-06	7.39e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—MMP9—Kawasaki disease	5.78e-06	7.38e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—CD4—Kawasaki disease	5.78e-06	7.38e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—CD4—Kawasaki disease	5.76e-06	7.36e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—CD4—Kawasaki disease	5.76e-06	7.36e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—CD4—Kawasaki disease	5.62e-06	7.18e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—VEGFA—Kawasaki disease	5.58e-06	7.13e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CCR5—Kawasaki disease	5.58e-06	7.13e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CCR5—Kawasaki disease	5.55e-06	7.09e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—CD4—Kawasaki disease	5.42e-06	6.92e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—CD4—Kawasaki disease	5.39e-06	6.89e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—CD4—Kawasaki disease	5.32e-06	6.79e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CCR5—Kawasaki disease	5.3e-06	6.77e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—MMP9—Kawasaki disease	5.29e-06	6.76e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—VEGFA—Kawasaki disease	5.24e-06	6.69e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—CD4—Kawasaki disease	5.19e-06	6.63e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—VEGFA—Kawasaki disease	5.19e-06	6.63e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—CD4—Kawasaki disease	5.15e-06	6.58e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—MMP9—Kawasaki disease	5.1e-06	6.51e-05	CbGpPWpGaD
Sunitinib—Haemoglobin—Acetylsalicylic acid—Kawasaki disease	5.07e-06	0.0353	CcSEcCtD
Sunitinib—NTRK1—Signaling Pathways—MMP9—Kawasaki disease	5.07e-06	6.47e-05	CbGpPWpGaD
Sunitinib—Haemorrhage—Acetylsalicylic acid—Kawasaki disease	5.04e-06	0.0352	CcSEcCtD
Sunitinib—FYN—Disease—CD4—Kawasaki disease	5e-06	6.39e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—CD4—Kawasaki disease	4.98e-06	6.36e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—MMP9—Kawasaki disease	4.91e-06	6.27e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—MMP9—Kawasaki disease	4.91e-06	6.27e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—MMP9—Kawasaki disease	4.79e-06	6.11e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—CD4—Kawasaki disease	4.76e-06	6.08e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—VEGFA—Kawasaki disease	4.75e-06	6.07e-05	CbGpPWpGaD
Sunitinib—Flushing—Acetylsalicylic acid—Kawasaki disease	4.68e-06	0.0326	CcSEcCtD
Sunitinib—ROCK1—Signaling Pathways—VEGFA—Kawasaki disease	4.58e-06	5.85e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—VEGFA—Kawasaki disease	4.55e-06	5.81e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—VEGFA—Kawasaki disease	4.41e-06	5.63e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—VEGFA—Kawasaki disease	4.41e-06	5.63e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—VEGFA—Kawasaki disease	4.3e-06	5.49e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—MMP9—Kawasaki disease	4.16e-06	5.31e-05	CbGpPWpGaD
Sunitinib—Anaemia—Acetylsalicylic acid—Kawasaki disease	4.06e-06	0.0283	CcSEcCtD
Sunitinib—Angioedema—Acetylsalicylic acid—Kawasaki disease	4.01e-06	0.028	CcSEcCtD
Sunitinib—IRAK1—Signaling Pathways—MMP9—Kawasaki disease	3.94e-06	5.04e-05	CbGpPWpGaD
Sunitinib—Leukopenia—Acetylsalicylic acid—Kawasaki disease	3.93e-06	0.0274	CcSEcCtD
Sunitinib—TYK2—Signaling Pathways—MMP9—Kawasaki disease	3.83e-06	4.89e-05	CbGpPWpGaD
Sunitinib—Convulsion—Acetylsalicylic acid—Kawasaki disease	3.8e-06	0.0265	CcSEcCtD
Sunitinib—Hypertension—Acetylsalicylic acid—Kawasaki disease	3.79e-06	0.0264	CcSEcCtD
Sunitinib—FGFR2—Signaling Pathways—MMP9—Kawasaki disease	3.78e-06	4.83e-05	CbGpPWpGaD
Sunitinib—Arthralgia—Acetylsalicylic acid—Kawasaki disease	3.74e-06	0.0261	CcSEcCtD
Sunitinib—Chest pain—Acetylsalicylic acid—Kawasaki disease	3.74e-06	0.0261	CcSEcCtD
Sunitinib—YES1—Signaling Pathways—VEGFA—Kawasaki disease	3.73e-06	4.77e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MMP9—Kawasaki disease	3.71e-06	4.74e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MMP9—Kawasaki disease	3.71e-06	4.74e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—VEGFA—Kawasaki disease	3.54e-06	4.52e-05	CbGpPWpGaD
Sunitinib—Shock—Acetylsalicylic acid—Kawasaki disease	3.52e-06	0.0246	CcSEcCtD
Sunitinib—FGFR1—Signaling Pathways—MMP9—Kawasaki disease	3.52e-06	4.5e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MMP9—Kawasaki disease	3.51e-06	4.49e-05	CbGpPWpGaD
Sunitinib—Thrombocytopenia—Acetylsalicylic acid—Kawasaki disease	3.51e-06	0.0245	CcSEcCtD
Sunitinib—TYK2—Signaling Pathways—VEGFA—Kawasaki disease	3.44e-06	4.39e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—VEGFA—Kawasaki disease	3.39e-06	4.34e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—VEGFA—Kawasaki disease	3.33e-06	4.26e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—VEGFA—Kawasaki disease	3.33e-06	4.26e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MMP9—Kawasaki disease	3.24e-06	4.14e-05	CbGpPWpGaD
Sunitinib—Dyspnoea—Acetylsalicylic acid—Kawasaki disease	3.19e-06	0.0223	CcSEcCtD
Sunitinib—PDGFRB—Signaling Pathways—MMP9—Kawasaki disease	3.17e-06	4.04e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—VEGFA—Kawasaki disease	3.16e-06	4.04e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—VEGFA—Kawasaki disease	3.16e-06	4.03e-05	CbGpPWpGaD
Sunitinib—Dyspepsia—Acetylsalicylic acid—Kawasaki disease	3.15e-06	0.022	CcSEcCtD
Sunitinib—FYN—Signaling Pathways—MMP9—Kawasaki disease	3.05e-06	3.9e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MMP9—Kawasaki disease	3.04e-06	3.88e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—VEGFA—Kawasaki disease	2.91e-06	3.72e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MMP9—Kawasaki disease	2.9e-06	3.7e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—VEGFA—Kawasaki disease	2.84e-06	3.63e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—VEGFA—Kawasaki disease	2.74e-06	3.5e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—VEGFA—Kawasaki disease	2.73e-06	3.48e-05	CbGpPWpGaD
Sunitinib—Hypersensitivity—Acetylsalicylic acid—Kawasaki disease	2.64e-06	0.0184	CcSEcCtD
Sunitinib—JAK2—Signaling Pathways—VEGFA—Kawasaki disease	2.6e-06	3.33e-05	CbGpPWpGaD
Sunitinib—Pruritus—Acetylsalicylic acid—Kawasaki disease	2.53e-06	0.0177	CcSEcCtD
Sunitinib—Diarrhoea—Acetylsalicylic acid—Kawasaki disease	2.45e-06	0.0171	CcSEcCtD
Sunitinib—Dizziness—Acetylsalicylic acid—Kawasaki disease	2.37e-06	0.0165	CcSEcCtD
Sunitinib—Vomiting—Acetylsalicylic acid—Kawasaki disease	2.28e-06	0.0159	CcSEcCtD
Sunitinib—Rash—Acetylsalicylic acid—Kawasaki disease	2.26e-06	0.0158	CcSEcCtD
Sunitinib—Dermatitis—Acetylsalicylic acid—Kawasaki disease	2.26e-06	0.0157	CcSEcCtD
Sunitinib—Nausea—Acetylsalicylic acid—Kawasaki disease	2.13e-06	0.0148	CcSEcCtD
